Skip to content
Recall Observatory FDA recall evidence

Drug product

Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC 342806263013

D-0107-2018

November 13, 2017

Class III

Product summary

Firm
Elite Laboratories Inc.
Event
Event 78502
Status
Terminated
Classification
Class III
Quantity
1264 bottles
Official record key
drug-enforcement:D-0107-2018

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lot #: P0910-017, Exp. 05/2019

Distribution pattern: NY only

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications